IMVT

Conviction 94HealthcareScan · Mon, Aug 10, 2026

IMVT$39.84-0.28%

ResistanceSupportVol 14Insider sell

Vol MA14 975.6K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Immunovant, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.immunovant.com ↗

Price39.84

Change-0.28%

Gap-0.49%

Rel volume1.70×

Avg volume950.32K

Avg $ vol37.42M

SMA 2039.38

SMA 5037.20

SMA 20028.69

Price vs 50+7.08%

Price vs 200+38.84%

MA stackbullish

50/200 cross—

Supertrendup · 36.50

RSI (14)57

MACD hist-0.13

MACD cross—

Stoch %K / %D77 / 74

ADX (14)18

+DI / −DI20 / 22

RSI divergence—

MACD divergence—

ATR %+3.65%

ADR %3.55%

52w high41.09

52w low14.69

From 52w high-3.04%

Above 52w low+171.20%

New 52w highNo

SqueezeOn · 14d

Bollinger width5.25%

%B0.72

Donchian pos69.07%

Donchian high41.21

Donchian low36.78

AVWAP (52w high)39.36

vs AVWAP high+1.21%

AVWAP (52w low)26.04

vs AVWAP low+52.99%

OBV trendFlat

Chaikin MF (20)0.16

Today vs 20d1.70×

Avg vol (14d)975.6K

Avg vol (20d)950.32K

Avg $ vol (20d)37.42M

Market cap—

RS 3m (vs SPY)+41.07%

RS 6m (vs SPY)+51.93%

RS line new highNo

Trend template8/8

Technical rank83.3

1 week+3.45%

1 month+0.33%

3 months+37.66%

6 months+47.28%

1 year+153.27%

YTD+53.76%

P/E-16.32

P/B11.22

P/S—

P/FCF-20.26

EPS-2.77

Div yield—

ROE-68.75%

ROA-59.31%

Debt/Eq—

Current7.27

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-22.17%

Price target50.36

Target upside26.03%

Analyst ratingBuy

Institutional58.09%

Ent. value7.46B

Revenue—

Net income-153.22M

Gross profit—

Free cash flow-407.32M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out205.31M

Employees315

ListedFri, Jun 21, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction94 / 100

Pattern quality—

Tech rank83.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance41.07

Support37.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMVT

All disclosures →

No recent disclosed trades by Congress in IMVT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMVT · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Gloria Melanie Chief Operating Officer · Common Stock · 2026-07-08	Sell	1.93K	$76K	2026-07-08	2026-07-10
Gloria Melanie Chief Operating Officer · Common Stock · 2026-07-08	Sell	106	$4K	2026-07-08	2026-07-10
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08	Sell	1.91K	$75K	2026-07-08	2026-07-10
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08	Sell	105	$4K	2026-07-08	2026-07-10
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08	Sell	1.4K	$55K	2026-07-08	2026-07-10
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08	Sell	77	$3K	2026-07-08	2026-07-10
Van Tuyl Christopher Chief Legal Officer · Common Stock · 2026-07-08	Sell	1.14K	$45K	2026-07-08	2026-07-10
Van Tuyl Christopher Chief Legal Officer · Common Stock · 2026-07-08	Sell	63	$3K	2026-07-08	2026-07-10
Van Tuyl Christopher Chief Legal Officer · Common Stock · 2026-06-18	Sell	2.63K	$93K	2026-06-18	2026-06-22
Fromkin Andrew J. Director · Common Stock · 2026-05-28	Sell	210.47K	$7.1M	2026-05-28	2026-05-29

SEC filings

EDGAR filings in IMVT · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.